FDA Approved: OXYBUTYNIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for the generic oxybutynin product developed by Zydus Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• oxybutynin (oxybutynin)

Snippet

SUPPL AP for OXYBUTYNIN (OXYBUTYNIN)